Search

Search Constraints

You searched for: Author/Creator Pietrantuono, Giuseppe

Search Results

1. Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real‐life experience. Issue 1 (1st November 2021)

2. Characterization and prognostic relevance of circulating microvesicles in chronic lymphocytic leukemia. Issue 6 (3rd June 2017)

3. Cytofluorimetric and immunohistochemical comparison for detecting bone marrow infiltration in non-Hodgkin lymphomas: a study of 354 patients. (January 2020)

4. Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials. Issue 4 (1st June 2022)

5. Flow cytometric evaluation of measurable residual disease in chronic lymphocytic leukemia: Where do we stand?. Issue 5 (21st June 2022)

6. Heavy/light chain ratio for the assessment of minimal residual disease in myeloma patients achieving complete response. (25th April 2017)

7. Italian Cytometry Society (GIC) endorsement of consensus recommendations for measurable residual disease in chronic lymphocytic leukemia. (18th November 2021)

8. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study. Issue 10373 (28th January 2023)

9. More on spontaneous regression of chronic lymphocytic leukemia: two new cases and potential role of lamivudine in a further patient with advanced disease and hepatitis B virus infection. Issue 8 (August 2014)